Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist plus HRT versus HRT alone for endometrial preparation before frozen embryo transfer in women with adenomyosis
IRCT20090526001952N13Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gonadotropin-releasing hormone agonist and estradiol valerate + dydrogesterone in adenomyosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: chemical pregnancy, clinical pregnancy and 1 more. Started May 2020; status: completed.
02
Drugs
gonadotropin-releasing hormone agonistestradiol valerate + dydrogesterone
03
Conditions
adenomyosis
Beyond the preview
Go deeper on IRCT20090526001952N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090526001952N13.